[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@StreetCred2017](/creator/twitter/StreetCred2017)
"@Quick2smile @ANKITSH85153215 Interesting and I think Inflarx did same thing w cSCC At end of the day it (C5a antagonist) may wind up being used in combination w some chemo agent. $AMGN $IFRX #PancreaticCancer needs anything that improves XX% survival rates. Compassionate use"  
[X Link](https://x.com/StreetCred2017/status/1975181788009115894) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-06T12:50Z XXX followers, XXX engagements


"@Investorclimber @Biotech_AI Gents - any best guess on upside with only X of X showing promise VS both CSU Yes HS -No: or visa versa Guggenheim called 5-10x but seems overly optimistic given need to finance P2b but both wld show pipeline potential. Also partner needed"  
[X Link](https://x.com/StreetCred2017/status/1978425820487069859) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-15T11:40Z XXX followers, XXX engagements


"@biotechsanya2 Also avacopan is approved for AAV so not exactly a failure for $AMGN but assume youre talking about the P1 Inflarx comparison of INF904 v avacopan"  
[X Link](https://x.com/StreetCred2017/status/1978589499119604212) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-15T22:31Z XXX followers, XXX engagements


"@biotechsanya2 Not sure if this helps comparing $AMGN avacopan v INF904 $IFRX"  
[X Link](https://x.com/StreetCred2017/status/1978605196461695371) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-15T23:33Z XXX followers, XXX engagements


"@3in5saved Still we need fda to say yes - or insurance willing to pay to use Gohibic off label -"  
[X Link](https://x.com/StreetCred2017/status/1979586654152098003) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-18T16:33Z XXX followers, XX engagements